OpenVSafe by OpenVAERS
Search V-safe

Y9V-33779-49037

1 vaccination 1 coded response 7 check-ins 1 free-text entry 0 call cases
Sex
Male
Age at first dose
16-20
ZIP prefix
559 / MN
Registered
2022-01-07
Relationship
Child or adolescent in my care
Guardian
EJX-27614-21327
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-01-07
    Registered in v-safe
  2. 2022-01-07
    Dose 1 — Pfizer-BioNTech
  3. 2022-01-07
    Health check-in — day 0, dose 1, dependent
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2022-01-08
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness
    Adult check-in
  5. 2022-01-09
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  6. 2022-01-11
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2022-01-13
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  8. 2022-01-14
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · Muscle or body aches
    Adult check-in
  9. 2022-01-21
    Survey response — day 14, dose 1, dependent
    MedDRA: Headache — Feeling: Fair
    Free text: Headaches
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12022-01-07Pfizer-BioNTech No

Free text

Release 11 — day 14, dose 1, dependent

2022-01-21

Symptoms: Headaches

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release